5-Year Safety Data Leaves Investigators Optimistic in Upadacitinib for AD Management
Dermatology Times
DECEMBER 11, 2023
Christopher Bunick, MD, PhD, presented the research during a late-breaking research session during the 2023 Revolutionizing Atopic Dermatitis Virtual Conference.
Let's personalize your content